Group 2 patients, characterized by a percentage of CD14hi CCR2+CX3CR1+ MO similar to that of healthy malaria exposed individuals, had a pro-inflammatory phenotype, a trend for higher levels of plasma cytokines, and a 10 fold higher mean peripheral parasitemia. The gene discussed is CCR2; the disease is parasitic infectious disease.